Introduction: Synbindin, originally identified as a neuronal cytoplasmic molecule, was found in glomeruli. The cDNA subtractive hybridization technique showed the mRNA expression of synbindin in glomeruli was downregulated in puromycin aminonucleoside (PAN) nephropathy, a mimic of minimal-change nephrotic syndrome. Methods: The expression of synbindin in podocytes was analyzed in normal rats and 2 types of rat nephrotic models, anti-nephrin antibody-induced nephropathy, a pure slit diaphragm injury model, and PAN nephropathy, by immunohistochemical analysis and RT-PCR techniques. To elucidate the function of synbindin, a gene silencing study with human cultured podocytes was performed. Results: Synbindin was mainly expressed at the slit diaphragm area of glomerular epithelial cells (podocytes). In both nephrotic models, decreased mRNA expression and the altered staining of synbindin were already detected at the early phase when proteinuria and the altered staining of nephrin, a key molecule of slit diaphragm, were not detected yet. Synbindin staining was clearly reduced when severe proteinuria was observed. When the cultured podocytes were treated with siRNA for synbindin, the cell changed to a round shape, and filamentous actin structure was clearly altered. The expression of ephrin-B1, a transmembrane protein at slit diaphragm, was clearly lowered, and synaptic vesicle-associated protein 2B (SV2B) was upregulated in the synbindin knockdown cells. Conclusion: Synbindin participates in maintaining foot processes and slit diaphragm as a downstream molecule of SV2B-mediated vesicle transport. Synbindin downregulation participates in slit diaphragm dysfunction. Synbindin can be an early marker to detect podocyte injury.

1.
Kawachi
H
,
Fukusumi
Y
.
New insight into podocyte slit diaphragm, a therapeutic target of proteinuria
.
Clin Exp Nephrol
.
2020 Mar
;
24
(
3
):
193
204
. .
2.
Kestila
M
,
Lenkkeri
U
,
Mannikko
M
,
Lamerdin
J
,
McCready
P
,
Putaala
H
,
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome
.
Mol Cell
.
1998 Mar
;
1
(
4
):
575
82
.
3.
Boute
N
,
Gribouval
O
,
Roselli
S
,
Benessy
F
,
Lee
H
,
Fuchshuber
A
,
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome
.
Nat Genet
.
2000 Apr
;
24
(
4
):
349
54
. .
4.
Donoviel
DB
,
Freed
DD
,
Vogel
H
,
Potter
DG
,
Hawkins
E
,
Barrish
JP
,
Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN
.
Mol Cell Biol
.
2001 Jul
;
21
(
14
):
4829
36
. .
5.
Kawachi
H
,
Koike
H
,
Kurihara
H
,
Sakai
T
,
Shimizu
F
.
Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli
.
J Am Soc Nephrol
.
2003 Jan
;
14
(
1
):
46
56
. .
6.
Miyauchi
N
,
Saito
A
,
Karasawa
T
,
Harita
Y
,
Suzuki
K
,
Koike
H
,
Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli
.
J Am Soc Nephrol
.
2006 Oct
;
17
(
10
):
2748
59
. .
7.
Hashimoto
T
,
Karasawa
T
,
Saito
A
,
Miyauchi
N
,
Han
GD
,
Hayasaka
K
,
Ephrin-B1 localizes at the slit diaphragm of the glomerular podocyte
.
Kidney Int
.
2007 Oct
;
72
(
8
):
954
64
. .
8.
Saito
A
,
Miyauchi
N
,
Hashimoto
T
,
Karasawa
T
,
Han
GD
,
Kayaba
M
,
Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys
.
Am J Physiol Regul Integr Comp Physiol
.
2011 Feb
;
300
(
2
):
R340
8
. .
9.
Takamura
S
,
Fukusumi
Y
,
Zhang
Y
,
Narita
I
,
Kawachi
H
.
Partitioning-defective-6-ephrin-B1 interaction is regulated by nephrin-mediated signal and is crucial in maintaining slit diaphragm of podocyte
.
Am J Pathol
.
2020 Feb
;
190
(
2
):
333
46
. .
10.
Fukusumi
Y
,
Yasuda
H
,
Zhang
Y
,
Kawachi
H
.
Nephrin-ephrin-B1-NHERF2-ezrin-actin axis is critical in podocyte injury
.
Am J Pathol
.
2021 Apr
;
191
:
1209
26
.
11.
Ethell
IM
,
Hagihara
K
,
Miura
Y
,
Irie
F
,
Yamaguchi
Y
.
Synbindin, a novel syndecan-2-binding protein in neuronal dendritic spines
.
J Cell Biol
.
2000 Oct
;
151
(
1
):
53
68
. .
12.
Fan
S
,
Feng
Y
,
Wei
Z
,
Xia
B
,
Gong
W
.
Solution structure of synbindin atypical PDZ domain and interaction with syndecan-2
.
Protein Pept Lett
.
2009
;
16
(
2
):
189
95
. .
13.
Kobayashi
N
,
Mundel
P
.
A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells
.
Cell Tissue Res
.
1998 Feb
;
291
(
2
):
163
74
. .
14.
National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals
.
The National Academies Collection: reports funded by National Institutes of Health
. In:
Guide for the care and use of laboratory animals
.
Washington, DC
:
National Academies Press (US) Copyright © 2011, National Academy of Sciences
.
15.
Orikasa
M
,
Matsui
K
,
Oite
T
,
Shimizu
F
.
Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody
.
J Immunol
.
1988 Aug
;
141
(
3
):
807
14
.
16.
Kawachi
H
,
Koike
H
,
Kurihara
H
,
Yaoita
E
,
Orikasa
M
,
Shia
MA
,
Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states
.
Kidney Int
.
2000 May
;
57
(
5
):
1949
61
. .
17.
Topham
PS
,
Kawachi
H
,
Haydar
SA
,
Chugh
S
,
Addona
TA
,
Charron
KB
,
Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin
.
J Clin Invest
.
1999 Dec
;
104
(
11
):
1559
66
. .
18.
Fukusumi
Y
,
Wakamatsu
A
,
Takashima
N
,
Hasegawa
E
,
Miyauchi
N
,
Tomita
M
,
SV2B is essential for the integrity of the glomerular filtration barrier
.
Lab Invest
.
2015 May
;
95
(
5
):
534
45
. .
19.
Fukusumi
Y
,
Zhang
Y
,
Yamagishi
R
,
Oda
K
,
Watanabe
T
,
Matsui
K
,
Nephrin-binding ephrin-B1 at the slit diaphragm controls podocyte function through the JNK pathway
.
J Am Soc Nephrol
.
2018 May
;
29
(
5
):
1462
74
. .
20.
Kawachi
H
,
Orikasa
M
,
Matsui
K
,
Iwanaga
T
,
Toyabe
S
,
Oite
T
,
Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen
.
Clin Exp Immunol
.
1992 Jan
;
88
(
3
):
399
404
. .
21.
Han
GD
,
Koike
H
,
Nakatsue
T
,
Suzuki
K
,
Yoneyama
H
,
Narumi
S
,
IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis
.
J Am Soc Nephrol
.
2003 Dec
;
14
(
12
):
3111
26
. .
22.
Saleem
MA
,
O’Hare
MJ
,
Reiser
J
,
Coward
RJ
,
Inward
CD
,
Farren
T
,
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression
.
J Am Soc Nephrol
.
2002 Mar
;
13
(
3
):
630
8
. .
23.
Verderame
M
,
Alcorta
D
,
Egnor
M
,
Smith
K
,
Pollack
R
.
Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells
.
Proc Natl Acad Sci U S A
.
1980 Nov
;
77
(
11
):
6624
8
. .
24.
Kawachi
H
,
Kurihara
H
,
Topham
PS
,
Brown
D
,
Shia
MA
,
Orikasa
M
,
Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes
.
Am J Physiol
.
1997 Dec
;
273
(
6
):
F984
93
. .
25.
Otaki
Y
,
Miyauchi
N
,
Higa
M
,
Takada
A
,
Kuroda
T
,
Gejyo
F
,
Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis
.
Am J Physiol Renal Physiol
.
2008 Nov
;
295
(
5
):
F1376
1387
. .
26.
Nakatsue
T
,
Koike
H
,
Han
GD
,
Suzuki
K
,
Miyauchi
N
,
Yuan
H
,
Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy
.
Kidney Int
.
2005 Jan
;
67
(
6
):
2239
53
. .
27.
Lehtonen
S
,
Lehtonen
E
,
Kudlicka
K
,
Holthöfer
H
,
Farquhar
MG
.
Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin
.
Am J Pathol
.
2004 Sep
;
165
(
3
):
923
36
. .
28.
Hsueh
YP
,
Yang
FC
,
Kharazia
V
,
Naisbitt
S
,
Cohen
AR
,
Weinberg
RJ
,
Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses
.
J Cell Biol
.
1998 Jul
;
142
(
1
):
139
51
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.